Ronald Blue Trust, Inc. Vertex Pharmaceuticals Inc Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 634 shares of VRTX stock, worth $298,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
634
Previous 3,605
82.41%
Holding current value
$298,214
Previous $1.45 Million
82.43%
% of portfolio
0.0%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,703Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.6 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.56 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.23 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...